XML 31 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended 123 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]        
Research and development expenses, net (Note 11) $ 1,789,301 $ 934,056 $ 1,005,108 $ 8,555,714
General and administrative expenses (Note 12) 544,145 457,495 165,156 2,161,734
Other income    (912)    (912)
Operating loss 2,333,446 1,390,639 1,170,264 10,716,536
Financing expenses, net (Note 13) 30,893 1,397,807 32,032 1,800,983
Loss for the year $ 2,364,339 $ 2,788,446 $ 1,202,296 $ 12,517,519
Loss per share (Basic and Diluted) (Note 15) $ 0.46 $ 0.7 $ 0.3  
Weighted average number of shares outstanding (Basic and Diluted) (Note 15) 5,091,330 4,034,706 3,995,805